Journal: |
International Medical Journal
Wolters Kluwer - Medknow
|
Volume: |
|
Abstract: |
Background
Proinflammatory cytokines play an important role in the establishment of
arteriolosclerosis and kidney injury. Inflammatory cytokines are involved in the
development of microvascular diabetic complications, including diabetic
nephropathy (DN). Interleukin-19 (IL-19) has vital functions in many
inflammatory processes and also can induce the angiogenesis of endothelial cells.
Objective
To investigate the role of IL-19 in the development of DN.
Patients and methods
A total of 112 participants were included and classified into four main groups: group
I was the control group, which included 28 age-matched and sex-matched persons;
group II included 28 patients with type 2 diabetes without nephropathy
(normoalbuminuria); group III included 28 patients with type 2 diabetes with
nephropathy (microalbuminuria); and group IV included 28 patient with type 2
diabetes with nephropathy (macroalbuminuria). All participants were subjected to
complete blood count, complete urine analysis, fasting and random blood glucose,
glycosylated hemoglobin (HbA1c), serum creatinine and urea, urinary albumin
excretion rate (UAE), albumin-creatinine ratio (ACR), lipid profile, and serum IL-19
level assays.
Results
C-reactive protein (CRP) and serum IL-19 levels were significantly higher in diabetic
patients compared with controls. IL-19 levels were significantly positively correlated
with serum creatinine, ACR, UAE, HbA1c, and CRP. Multivariable logistic
regression analysis showed that IL-19 levels were independently associated
with patients with DN.
Conclusion
IL-19 levels were elevated in patients with DN and were positively correlated with
ACR, UAE, HbA1c, and CRP. IL-19 may play an important role that contributes to
the progression of DN.
|
|
|